Safety and Efficacy of Skin Cleanser Contained Roselle Extract in Acne

Sponsor
Thammasat University (Other)
Overall Status
Unknown status
CT.gov ID
NCT00701480
Collaborator
National Research Council of Thailand (Other)
50
1
2
5
9.9

Study Details

Study Description

Brief Summary

Skin cleanser for daily used is essential and one of the most common questions asked by acne patients. There are studies reported beneficial effects of cleansers in acne treatment. Extracts of plants as active ingredients in skin cleansers are increasingly popular worldwide. Roselle is a common tropical shrub. Usually, the calyces of the plant have been used to make beverages but it also used in Thai traditional medicine for several purposes including as antiseptic and astringent. The extract of roselle showed antioxidant and keratolytic effects from previous studies which fit to the pathogenesis of acne. The aims of the study is to determine the safety and efficacy of skin cleanser contained roselle extract in acne.

Condition or Disease Intervention/Treatment Phase
  • Other: skin cleanser contained Hibiscus sabdariffa extract
  • Other: marketed skin cleanser
Phase 2

Detailed Description

Acne is one of the most common skin problems in teenagers and adolescents. Keys pathogenesis of the disease are 1.abnormal hypercornification of pilosebaceous duct,2.excess sebum production, 3.inflammation, 4.the present of Propionibacterium acnes. Treatments often include combination of topical and oral medications according to degree of acne severities. Acne medications can lead to drying and irritation of skin. Proper skin cleansing is important and can improve tolerability and efficacy of acne treatment.

Traditional medicine with longstanding used of herbal ingredients for skin problems and beauty is increasing more popular. Hibiscus sabdariffa L.(Roselle) is used as food, drink and topical formulation for skin infection in Thai traditional medicine. The extract from calyces contained polyphenolic compounds and anthocyanins that showed antioxidant and keratolytic activities. There for skin cleanser with Roselle extract might be benefit to acne by loosen comedone, reduce Propionibacterium acne and prevent keratinocyte injury.

The purposes of this study is to evaluate skin cleanser contained Roselle extract in two aspects ; 1. safety for irritation and allergic effects, 2. efficacy in acne as cleanser alone and as supportive care with others acne therapies.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Randomized Double-Blind Case Control Study of Safety and Efficacy of Skin Cleanser Contained Hibiscus Sabdariffa Extract in Acne Treatment.
Study Start Date :
Apr 1, 2008
Anticipated Primary Completion Date :
Jul 1, 2008
Anticipated Study Completion Date :
Sep 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

skin cleanser contained Hibiscus sabdariffa

Other: skin cleanser contained Hibiscus sabdariffa extract
face washing 2-3 times/day
Other Names:
  • Roselle skin cleanser
  • Active Comparator: 2

    marketed skin cleanser

    Other: marketed skin cleanser
    face washing 2-3 times/day
    Other Names:
  • Clean and Clear
  • Clearasil
  • Neutrogena
  • Outcome Measures

    Primary Outcome Measures

    1. 1. Safety evaluation: Patch test 2. Efficacy evaluation: Acne lesions counts/ acne severity grading [6 weeks]

    Secondary Outcome Measures

    1. 1. Safety evaluation: "a." Skin properties by visual and tactile features., "b." Biophysical parameters of skin. 2.Efficacy evaluation: Patient assessments. [6 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • age 12-45 yrs,both sex

    • clinical diagnosis of mild to moderately severe acne vulgaris(grade 1-3)

    • have at least 10 facial acne lesions

    • not changing any acne treatment during study period

    • able to follow up according to protocol

    • Written informed consent

    Exclusion Criteria:
    • pregnant or breast feeding

    • severe acne(grade4 or nodulocystic acne)

    • treated with isotretinoin orally during the last 3 months

    • have other systemic disease or illness

    • have allergic history to Roselle

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Thammasat University KlongLaung Pathumtanee Thailand 12120

    Sponsors and Collaborators

    • Thammasat University
    • National Research Council of Thailand

    Investigators

    • Principal Investigator: Mali - Achariyakul, MD., Thammasat University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00701480
    Other Study ID Numbers:
    • MTU-E-1-002/51
    First Posted:
    Jun 19, 2008
    Last Update Posted:
    Jun 19, 2008
    Last Verified:
    Jun 1, 2008
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 19, 2008